Market Research

AI Diagnostic Market was valued at USD 288.1 million in 2019 and is anticipated to reach USD 2043.91 million by 2027, at a CAGR of 32.3% during the forecast period

Aug 7, 2020 10:00 PM ET

iCrowd Newswire – Aug 7, 2020

The GlobalArtificial Intelligence Diagnostic Market was valued at USD 288.1 million in 2019 and is anticipated to strike the figure of USD 2043.91 million by 2027, at a CAGR of 32.3% during the projection period.Artificial intelligence (AI) refers to forming unique systems with the help of procedures and software to accomplish specific tasks without human interference and commands. Artificial intelligence involves the application of several technologies, such as machine learning, natural language processing, reasoning, and insight.

Request to get the report sample pages at : https://www.blueweaveconsulting.com/global-artificial-intelligence-diagnostic-market-bwc20108/report-sample

AI is used in healthcare to approximate human perception and to derive findings of complicated medical and diagnostic imaging data. It is mainly used in healthcare to find the relationship between treatment techniques and patient outcomes. AI programs are deployed in medical practices such as diagnostic procedures, drug growth, personalized medicines, and patient testing care. For instance, AI could aid in clinical procedures by checking the vital signs, probing questions, and giving patients prescriptions. AI systems can also be used for warnings and reminders, image interpretation, information retrieval, and treatment plan during medical procedures.

Deep learning technology is used for image acknowledgement, signal recognition, and data removal and is the most extensively used form of AI technology. Growing requests for reducing diagnostic costs, improving patient care, and reducing machine downtime are the factors driving the usage of artificial intelligence in diagnostics. Besides, growing requests for low-cost diagnostic methods, actual and competent report testing and quick diagnostic data generation are some other factors expected to propel the market for AI in diagnostics.

With the growth of deep learning and neural networks, artificial intelligence (AI) has gained learning competences. The result is that few new AIs can now detect more useful patterns than human eyes. It paves the way for the emergence of a new age medical diagnostic devices proficient in surpassing the best diagnosis skills of the doctors. Because artificial intelligence can imagine, the advantage of its proficiency can be availed by a significant number of patients. Moreover, increasing strategic partnerships and collaborations among numerous AI solution providers and health facilities positively influences market development.

Software segment in the AI healthcare market is likely to fetch the highest CAGR during the prediction period. Many companies offer emerging software solutions for various healthcare uses; this is a critical factor adding to the development of the software segment. The growing acceptance of AI-driven healthcare informatics solutions and healthcare operational support by hospitals and other healthcare service providers is predicted to grow the demand in the latter part of the prediction period.

Enquire Before Purchase : https://www.blueweaveconsulting.com/global-artificial-intelligence-diagnostic-market-bwc20108/enquire-before-purchase

The Asia Pacific is predicted to be the most profitable market growing at a remarkable growth rate during the forecast period. An increasing number of government initiatives for the adoption of AI-based diagnostic technologies by healthcare practitioners and other healthcare organizations and increasing savings by nonprofit organizations and private companies to achieve better information exchange improved clinical outcomes. Cost efficiencies are some of the main points predicted to drive the development of the market for AI in diagnostics in the Asia Pacific during the prediction period.

The major companies in this market are IBM Corporation, Google, Inc., NVIDIA Corporation, Microsoft Corporation, iCarbonX, Next IT Corp., CloudMex Inc., Carescore, Atomwise Inc., Zephyr Health Inc., Deep Genomics Inc., Medtronic Plc., Koninkiljke Philips N.V., and Oncora Medical, Inc. and others.

About Us

BlueWeave Consulting is a one-stop solution for market intelligence regarding various products and services online & offline. We offer worldwide market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality performance and nourishing the long-lasting relationships with its clients.

Contact Information:

Contact:

Blueweave consulting
Toll-free: +1-866-658-6826
International: +1-425-320-4776
Email: [email protected]
Web: https://www.blueweaveconsulting.com


iCrowdNewswire

Keywords:    AI Diagnostic Market, AI Diagnostic Market Size, AI Diagnostic Market Share, AI Diagnostic Market Growth, AI Diagnostic Market Trends, AI Diagnostic Market Forecast